Long noncoding RNA intersectin 1-2 gradually declines during adalimumab treatment, and its reduction correlates with treatment efficacy in patients with ankylosing spondylitis
Crossref DOI link: https://doi.org/10.1007/s10787-021-00854-3
Published Online: 2021-08-18
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Mingwu
Zhou, Xianjie http://orcid.org/0000-0001-9059-6212
Text and Data Mining valid from 2021-08-18
Version of Record valid from 2021-08-18
Article History
Received: 10 May 2021
Accepted: 20 July 2021
First Online: 18 August 2021
Declarations
:
: The authors declare that they have no conflict of interest.